Pyxis Oncology (PYXS) Price to Book (2021 - 2026)

Pyxis Oncology (PYXS) has reported Price to Book for 6 consecutive years, with 16.69 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Book rose 2044.25% year-over-year to 16.69 in Q2 2026; TTM through Jun 2026 was 16.69, a 2044.25% increase from a year earlier, with the FY2025 full-year figure at 1.35, up 74.24% from the prior year.
• Price to Book was 16.69 for Q2 2026 at Pyxis Oncology, up from 1.35 in the prior quarter.
• Over five years, Price to Book peaked at 16.69 in Q2 2026 and troughed at 0.29 in Q4 2022.
• A 5-year average of 1.8 and a median of 0.77 in 2024 frame the typical range for Price to Book.
• Across the five-year window, Price to Book tumbled 56.93% in 2025 and soared 2044.25% in 2026, its largest moves.
• Over 5 years, Price to Book stood at 0.29 in 2022, then jumped by 120.02% to 0.64 in 2023, then advanced by 20.89% to 0.77 in 2024, then surged by 74.24% to 1.35 in 2025, then soared by 1136.45% to 16.69 in 2026.
• The last three Price to Book figures came in at 16.69 (Q2 2026), 1.35 (Q4 2025), and 2.01 (Q3 2025), per Business Quant data.